HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

PCSK9 inhibitors like Repatha have real side effects and a shorter safety record

Louis Nervegna · Apr 15, 2024 · ♥ 8 reactions · 14 comments · original Facebook post
PCSK9, ezetimibe & newer drugsStatins
AI summary & key facts

Louis pushes back on the claim that PCSK9 inhibitors lack significant side effects. The manufacturer lists flu-like symptoms, back pain and high blood sugar as the most common, and long-term effects are not yet known, which is why guidance reserves them for high-risk patients or those who cannot tolerate statins.

It is false that PCSK9 inhibitors like repatha do not have significant side effects.

The most common side effects of repatha are flu-like symptoms, back pain, and high blood sugar. And there are multiple other less common side effects.

The manufacturer of the drug (Amgen) officially lists these as the most common side effects in their documentation on the drug (see link below).

.

repatha.comRepatha side effectsrepatha.com

The jury is still out on whether or not they are safer than statins. People making this claim are not doing so based on the preponderance of evidence that we have so far. Statins have been studied for decades and the side effects are well known. PCSK9 inhibitors are still relatively new, and we do not yet know the long term side effects.

Because of the unknowns, the evidence-based guidance is that PCSK inhibitors should be reserved for high risk patients or people who can not tolerate statins.

#pcsk9HD #statinsHD

Research cited

← newer: Nocebo effect explained about 90% of symptoms in patients wholder: Snacks supply about 25% of US adults' calories in a 23,000-a →